Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
This is a great company but I think it has failed to produce results for shareholders because they have not listed on LSE. They have had plenty of good news but still suffer from huge selling pressure from somewhere.
I agree. A great company and a good leader in Geremy. Alot of Stillcanna shareholders caught up in the last bubble. One big annoucement and our share price will double too. Lots of opportunities for us. Wholesale potential is massive. Another acquisition probably needed (on the medical side). Buying Stillcanna was expensive for me as a shareholder but the upside will sort that out.
I agree too, which is why I have been in for so long. Anybody any idea what the profits were for last quarter... I know it was reported as record breaking, but can't recall seeing the actual figures. I'd like to see a dividend with this in the future. If the company are making decent profits, then I'd like to see a bit back!
Quite right. To be honest, I'm just glad there's a few chatting in here... It's been very quiet for a long long time!! Ha. Looks like another blue day, ticking up nicely on the CSE.
I thought I was alone on Twitter, glad to see theres others :) was massively shafted by the reverse take over. Good to see the movement today! Agree with the LSE listing and also would be great to see some PR during this time. Stocks like Kanabo smashing it!! Probably got into this space too prematurely! live and learn. would at least like to come out evens!! We need a good CEO and some marketing!
Completely agree Mulaa. I was shafted too, I suspect many were. Yes maybe we did enter this space prematurely, however you would like to think that this puts us in a strong position, particularly in the UK. Couldn’t agree more with the marketing.
Agree MPBUK, hopefully come April after the Noval Foods approval we will all be sitting back and reaping the profits!
I’m in the same boat as you guys. First mover advantage was what caught my eye. That and the projected mcp for the cbd industry for 2025. This company is in a good position to really do well here. It’s a high end seed to shelf business. Every part of the plants life can be traced.
I think we will start seeing some upside when the FSA start cracking down on cbd products.
We shouldn’t have a problem getting our novel food application passed.
Sounds like I am in the same boat as everyone else!
There seems to be some movement at the moment. BOD changes, Novel Foods approval in April, hype around other cannabis industries in America/Canada and the launch of Kananbo in the UK. My point is do we think this is a buy because of all this? If we hadn't already put our money in and maybe because we have would you put more money in now to ride it back up and even out some of those losses? I would be interested to know people's opinions.
Good question. I've considered lowering my average recently at the low levels, however with no movement for such a long time I resisted. I'm also in for plenty here already! We certainly need others to come on board to try and raise the sp, and maybe the movement currently will encourage this... Here's hoping. I think I need 18p to break even here...
Well that was how all this started, looking at the medicinal side. The CBD was almost to fill the time gap whilst regulations changed.